(Q43890172)

English

Determination of nelfinavir free drug concentrations in plasma by equilibrium dialysis and liquid chromatography/tandem mass spectrometry: important factors for method optimization

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Determination of nelfinavir free drug concentrations in plasma by equilibrium dialysis and liquid chromatography/tandem mass spectrometry: important factors for method optimization (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

Terrence F. Blaschke

object named as

Terrence F Blaschke

4

0 references

author name string

Claudia Herforth

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Judith A Stone

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Anura L Jayewardene

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Fang Fang

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Toshiro Motoya

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Francesca T Aweeka

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

European Journal of Pharmaceutical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

185-195

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of protein binding for the interpretation of serum or plasma drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum protein pattern in normal pregnancy with special reference to acute-phase reactants

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for monitoring free drug levels

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of unbound drug concentration and protein-drug binding fraction in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of microultrafiltration devices for determination of protein binding

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-protein binding sites. New trends in analytical and experimental methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nelfinavir mesylate: a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma protein binding and therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug protein binding in chronic renal failure: Evaluation of nine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900220-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0928-0987(01)00220-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43890172&oldid=2144947629"